COVID-19 Clinical footprint to infer about mortality

04/15/2021
by   Carlos E. Rodríguez, et al.
0

Information of 1.6 million patients identified as SARS-CoV-2 positive in Mexico is used to understand the relationship between comorbidities, symptoms, hospitalizations and deaths due to the COVID-19 disease. Using the presence or absence of these latter variables a clinical footprint for each patient is created. The risk, expected mortality and the prediction of death outcomes, among other relevant quantities, are obtained and analyzed by means of a multivariate Bernoulli distribution. The proposal considers all possible footprint combinations resulting in a robust model suitable for Bayesian inference.

READ FULL TEXT
POST COMMENT

Comments

There are no comments yet.

Authors

page 13

page 14

page 15

page 16

11/19/2020

Predicting Patient COVID-19 Disease Severity by means of Statistical and Machine Learning Analysis of Blood Cell Transcriptome Data

Introduction: For COVID-19 patients accurate prediction of disease sever...
04/19/2021

Machine learning approach to dynamic risk modeling of mortality in COVID-19: a UK Biobank study

The COVID-19 pandemic has created an urgent need for robust, scalable mo...
01/11/2021

Where you live matters: a spatial analysis of COVID-19 mortality

The COVID-19 pandemic has caused   2 million fatalities. Significant pro...
11/07/2020

GP-LVM of categorical data from test-positive COVID-19 pregnant women

Novel coronavirus disease 2019 (COVID-19) is rapidly spreading throughou...
01/19/2021

Continual Deterioration Prediction for Hospitalized COVID-19 Patients

Leading up to August 2020, COVID-19 has spread to almost every country i...
03/04/2021

Learning to Predict with Supporting Evidence: Applications to Clinical Risk Prediction

The impact of machine learning models on healthcare will depend on the d...
This week in AI

Get the week's most popular data science and artificial intelligence research sent straight to your inbox every Saturday.